Access to Experimental Drugs in
Terminal Illness: Ethical Issues helps you understand the dilemma of those suffering from terminal illnesses who are denied legal access to experimental, potentially life-saving drugs and then pressured into clinical tests designed to test and approve the very same drugs. You'll see the current need for ethics and policy reform in this area, and you'll get updated information on the development of
protease inhibitors and other medications designed to prolong the life of those stricken with
terminal disease.
